565 related articles for article (PubMed ID: 19120336)
1. Enhancement of bioavailability by lowering of fat content in topical formulations.
Wirén K; Frithiof H; Sjöqvist C; Lodén M
Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability, antipsoriatic efficacy and tolerability of a new light cream with mometasone furoate 0.1%.
Korting HC; Schöllmann C; Willers C; Wigger-Alberti W
Skin Pharmacol Physiol; 2012; 25(3):133-41. PubMed ID: 22353786
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
Wiedersberg S; Naik A; Leopold CS; Guy RH
Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
[TBL] [Abstract][Full Text] [Related]
4. In vitro antioxidant activity and in vivo efficacy of topical formulations containing vitamin C and its derivatives studied by non-invasive methods.
Campos PM; Gonçalves GM; Gaspar LR
Skin Res Technol; 2008 Aug; 14(3):376-80. PubMed ID: 19159387
[TBL] [Abstract][Full Text] [Related]
5. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
[TBL] [Abstract][Full Text] [Related]
6. Influence of nanosized delivery systems with benzyl nicotinate and penetration enhancers on skin oxygenation.
Abramović Z; Sustarsic U; Teskac K; Sentjurc M; Kristl J
Int J Pharm; 2008 Jul; 359(1-2):220-7. PubMed ID: 18472233
[TBL] [Abstract][Full Text] [Related]
7. Formulation effects of topical emulsions on transdermal and dermal delivery.
Otto A; du Plessis J; Wiechers JW
Int J Cosmet Sci; 2009 Feb; 31(1):1-19. PubMed ID: 19134123
[TBL] [Abstract][Full Text] [Related]
8. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
[TBL] [Abstract][Full Text] [Related]
9. Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability.
Smith EW; Meyer E; Haigh JM
Arzneimittelforschung; 1990 May; 40(5):618-21. PubMed ID: 2383308
[TBL] [Abstract][Full Text] [Related]
10. Formulation and in-vivo evaluation of a cosmetic multiple emulsion containing vitamin C and wheat protein.
Akhtar N; Yazan Y
Pak J Pharm Sci; 2008 Jan; 21(1):45-50. PubMed ID: 18166519
[TBL] [Abstract][Full Text] [Related]
11. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
[TBL] [Abstract][Full Text] [Related]
12. A novel foam vehicle for delivery of topical corticosteroids.
Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations.
Reichling J; Landvatter U; Wagner H; Kostka KH; Schaefer UF
Eur J Pharm Biopharm; 2006 Oct; 64(2):222-8. PubMed ID: 16846726
[TBL] [Abstract][Full Text] [Related]
14. Time of erythema onset after application of methyl nicotinate ointments as response parameter: influence of penetration kinetics and enhancing agents.
Remane Y; Leopold CS
Skin Pharmacol Physiol; 2006; 19(6):303-10. PubMed ID: 16931897
[TBL] [Abstract][Full Text] [Related]
15. Multivesicular emulsion: a novel, controlled-release delivery system for topical dermatological agents.
Bikowski J; Shroot B
J Drugs Dermatol; 2006; 5(10):942-6. PubMed ID: 17373142
[TBL] [Abstract][Full Text] [Related]
16. Photostability and efficacy studies of topical formulations containing UV-filters combination and vitamins A, C and E.
Gaspar LR; Campos PM
Int J Pharm; 2007 Oct; 343(1-2):181-9. PubMed ID: 17614223
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of in vivo efficacy of topical formulations containing soybean extract.
Georgetti SR; Casagrande R; Verri WA; Lopez RF; Fonseca MJ
Int J Pharm; 2008 Mar; 352(1-2):189-96. PubMed ID: 18079076
[TBL] [Abstract][Full Text] [Related]
18. In vivo skin effects of a dimethylaminoethanol (DMAE) based formulation.
Tadini KA; Campos PM
Pharmazie; 2009 Dec; 64(12):818-22. PubMed ID: 20095140
[TBL] [Abstract][Full Text] [Related]
19. Formulation and characterization of a cream containing terminalia chebula extract.
Akhtar N; Khan AB; Muhammad S; Ahmed M; Khan HM; Rasool F; Saeed T
Forsch Komplementmed; 2012; 19(1):20-5. PubMed ID: 22398922
[TBL] [Abstract][Full Text] [Related]
20. [Significance of urea in external therapy].
Wohlrab W
Hautarzt; 1989; 40 Suppl 9():35-41. PubMed ID: 2681075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
